Other
Publications & Posters
4SC-202
|
16-19 November, 2010 22nd EORTC-NCI-AACR Symposium, Berlin, Germany |
Preclinical characterization of 4SC-202, a noval isotype specific HDAC inhibitor | |
4SC-203
|
23-27 September, 2011 16th ECCO European Multidisciplinary Cancer Congress, Stockholm, Sweden |
Preclinical and Clinical Development of 4SC-203, a Novel Multi-Target Kinase Inhibitor |
4SC-207
|
16-19 November, 2010 22nd EORTC-NCI-AACR Symposium, Berlin, Germany |
4SC-207, a novel and highly potent anti-mitotic agent, active also on PgP expressing tumor cells resistant to other chemotherapeutic drugs, induces complete tumor stasis in in vivo tumour models | |
Kv1.3
|
27-29 June, 2011 Aurora Ion Channel Retreat 2011, Vancouver, Kanada |
4SC’s Kv1.3 Inhibitors: Efficacy in Animal Models | |
|
27-31 March, 2011 241st ACS National Meeting, Anaheim, California, USA |
Kv1.3 as Therapeutic Target - PoCAnimal Models |
CSC1
|
12-16 November, 2011 AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics, San Francisco, USA |
Targeting cancer stem cells with small molecule inhibitors" | |
|
16-18 March, 2011 16th International Cancer Congress, Heinrich-Heine-Universität, Düsseldorf, Germany |
Eliminating Cancer Stem Cells by Inhibition of the Wnt Pathway via Small Molecule Kinase Inhibitors |